Company Data
Sonnet BioTherapeutics Holdings Inc.
Ticker
SONN
Current Price
$1.52 -4.4%
Market Cap
$4.7M
Price Target
Refer to Report
Volume
34.2K
52wk Range
$1.41 - $18.7192
Overview
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm’s pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.